Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2. (Q38902030)

7 September 2017

title

Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2. (English)

1 reference

G protein-coupled receptor

7 September 2017

main subject

0 references

cervix uterine cancer

1 reference

Qiong Zhang

1 reference

7 September 2017

Yuan-Zhe Wu

1 reference

7 September 2017

Yan-Mei Zhang

1 reference

7 September 2017

Xiao-Hong Ji

1 reference

7 September 2017

Qun Hao

1 reference

7 September 2017

publication date

6 March 2015

1 reference

Cell Biochemistry & Function

7 September 2017

published in

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

134-142

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

7 September 2017

cites work

1 reference

Epigenetic alterations in cervical carcinogenesis

21 January 2018

1 reference

The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis.

21 January 2018

1 reference

Oral contraceptives and reproductive system cancer

21 January 2018

1 reference

Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971.

21 January 2018

1 reference

The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review

21 January 2018

1 reference

Estrogen receptor-alpha knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract

21 January 2018

1 reference

G protein-coupled receptors: novel targets for drug discovery in cancer

21 January 2018

1 reference

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

21 January 2018

1 reference

Mechanisms of estrogen signaling and gene expression via GPR30

21 January 2018

1 reference

17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.

21 January 2018

1 reference

The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo

21 January 2018

1 reference

G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells

21 January 2018

1 reference

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

21 January 2018

1 reference

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells

21 January 2018

1 reference

The unfolding stories of GPR30, a new membrane-bound estrogen receptor.

21 January 2018

1 reference

The G-protein-coupled estrogen receptor GPER in health and disease

21 January 2018

1 reference

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

21 January 2018

1 reference

The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

21 January 2018

1 reference

Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest

21 January 2018

1 reference

Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells

21 January 2018

1 reference

The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation.

21 January 2018

1 reference

The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization

21 January 2018

1 reference

The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells

21 January 2018

1 reference

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells

21 January 2018

1 reference

Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.

21 January 2018

1 reference

The GPER agonist G-1 induces mitotic arrest and apoptosis in human vascular smooth muscle cells independent of GPER.

21 January 2018

1 reference

GPER functions as a tumor suppressor in triple-negative breast cancer cells

21 January 2018

1 reference

GPER-1 acts as a tumor suppressor in ovarian cancer

21 January 2018

1 reference

Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells.

21 January 2018

1 reference

MAPK signal pathways in the regulation of cell proliferation in mammalian cells

21 January 2018

1 reference

How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CBF.3097

1 reference

7 September 2017

1 reference